6.03
Schlusskurs vom Vortag:
$5.64
Offen:
$5.8534
24-Stunden-Volumen:
16,286
Relative Volume:
0.25
Marktkapitalisierung:
$48.66M
Einnahmen:
$32.03M
Nettoeinkommen (Verlust:
$-13.97M
KGV:
-3.5704
EPS:
-1.6889
Netto-Cashflow:
$-8.25M
1W Leistung:
-2.27%
1M Leistung:
-20.45%
6M Leistung:
+21.82%
1J Leistung:
-9.87%
Electrocore Inc Stock (ECOR) Company Profile
Firmenname
Electrocore Inc
Sektor
Branche
Telefon
973-290-0097
Adresse
200 FORGE WAY, ROCKAWAY
Compare ECOR vs ABT, SYK, MDT, BSX, EW
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
|
ECOR
Electrocore Inc
|
6.02 | 45.59M | 32.03M | -13.97M | -8.25M | -1.6889 |
|
ABT
Abbott Laboratories
|
102.51 | 177.03B | 44.33B | 6.50B | 7.40B | 3.717 |
|
SYK
Stryker Corp
|
328.77 | 124.89B | 25.12B | 3.25B | 4.28B | 8.3984 |
|
MDT
Medtronic Plc
|
86.69 | 110.08B | 35.48B | 4.64B | 5.41B | 3.582 |
|
BSX
Boston Scientific Corp
|
62.59 | 93.53B | 20.08B | 2.89B | 3.66B | 1.9391 |
|
EW
Edwards Lifesciences Corp
|
80.08 | 45.84B | 6.07B | 1.06B | 1.34B | 1.8063 |
Electrocore Inc Stock (ECOR) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2020-08-14 | Hochstufung | BTIG Research | Neutral → Buy |
| 2019-11-14 | Herabstufung | JMP Securities | Mkt Outperform → Mkt Perform |
| 2019-09-26 | Fortgesetzt | Cantor Fitzgerald | Neutral |
| 2019-05-30 | Herabstufung | Cantor Fitzgerald | Overweight → Neutral |
| 2019-05-15 | Herabstufung | BTIG Research | Buy → Neutral |
| 2019-05-09 | Eingeleitet | Noble Capital Markets | Outperform |
| 2018-09-21 | Eingeleitet | Cantor Fitzgerald | Overweight |
Alle ansehen
Electrocore Inc Aktie (ECOR) Neueste Nachrichten
electroCore Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4) - The Manila Times
electroCore adds a COO and sales VP, with 100,000 RSUs attached - Stock Titan
Momentum Shift: Can electroCore Inc deliver alphaQuarterly Trade Review & Reliable Breakout Stock Forecasts - baoquankhu1.vn
electroCore (ECOR) Secures Two New U.S. Patents for Vagus Nerve Modulation - gurufocus.com
electroCore receives two U.S. patents for nerve stimulation tech By Investing.com - Investing.com Canada
electroCore wins 2 U.S. patents, with terms potentially reaching 2039 - Stock Titan
Published on: 2026-03-28 12:14:09 - baoquankhu1.vn
Growth Value: Whats the analyst consensus on electroCore IncEntry Point & Precise Entry and Exit Recommendations - baoquankhu1.vn
Retail Surge: Is electroCore Inc being accumulated by smart money2026 Chart Watch & AI Optimized Trade Strategies - baoquankhu1.vn
Earnings Beat: Is electroCore Inc stock overvalued or fairly priced2026 Short Interest & Free Real-Time Market Sentiment Alerts - baoquankhu1.vn
Aug Update: Is electroCore Inc stock a value trap2026 WrapUp & Safe Swing Trade Setup Alerts - baoquankhu1.vn
Aug Retail: Is electroCore Inc stock a value trap2026 Patterns & Reliable Price Action Trade Plans - baoquankhu1.vn
Market Review: Will electroCore Inc benefit from rate cuts2026 Trends & Risk Controlled Swing Trade Alerts - baoquankhu1.vn
ElectroCore outlines 30% revenue growth potential for 2026 as leadership transition advances - MSN
electroCore Inc (ECOR) Q4 2025 Earnings Call Highlights: Record Revenue and Strategic Growth ... By GuruFocus - Investing.com Canada
Why Is electroCore, Inc. (ECOR) Stock Down Today? - Meyka
electroCore Inc (ECOR) Q4 2025 Earnings Call Highlights: Record Revenue and Strategic Growth Initiatives - gurufocus.com
Hedge Fund Moves: Does electroCore Inc meet Warren Buffetts criteria2026 Catalysts & Expert Curated Trade Setup Alerts - baoquankhu1.vn
Analysts Offer Predictions for electroCore FY2030 Earnings - MarketBeat
CEO Moves: Should value investors consider electroCore IncMarket Risk Analysis & Reliable Entry Point Alerts - baoquankhu1.vn
Electrocore’s gammaCore Pipeline Faces Material Trial Disruption Risks From Regulatory, Enrollment and Operational Challenges - The Globe and Mail
Analysts Offer Insights on Healthcare Companies: Electrocore (ECOR) and Regeneron (REGN) - The Globe and Mail
ElectroCore FY earnings preview - MSN
Analysts Offer Insights on Healthcare Companies: Annexon Biosciences (ANNX) and Electrocore (ECOR) - The Globe and Mail
ElectroCore Earnings Call: Growth Surges, Losses Deepen - The Globe and Mail
Major Insider Move at ElectroCore Signals Growing Confidence From the Top - TipRanks
ECOR Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
ElectroCore, Inc. (NASDAQ:ECOR) Q4 2025 earnings call transcript - MSN
ElectroCore, Inc. (ECOR) reports Q4 loss, lags revenue estimates - MSN
electroCore stock maintained at Buy by H.C. Wainwright, $18 target - in.investing.com
electroCore, Inc. (NASDAQ:ECOR) Q4 2025 Earnings Call Transcript - Insider Monkey
electroCore (ECOR) director Errico exercises warrants to acquire 42,055 shares - Stock Titan
electroCore reports 27% revenue growth, CEO to retire By Investing.com - in.investing.com
electroCore Q4 2025 Earnings Call Transcript - MarketBeat
electroCore, Inc. 2025 Annual Report: Marketed Products, Business Strategy, Risks, and Regulatory Overview - Minichart
electroCore, Inc. Q4 2025 Earnings Call Summary - Yahoo Finance
electroCore (NASDAQ:ECOR) Releases Quarterly Earnings Results, Beats Estimates By $0.01 EPS - MarketBeat
electroCore (ECOR) Q4 2025 Earnings Transcript - AOL.com
electroCore, Inc. (ECOR) Posts Fourth Quarter Loss, Misses Revenue Expectations - Bitget
Electrocore’s 2025 Earnings Call: Quell Sales Channels, VA Contract Status, and Fibromyalgia Launch Timelines Clash - Bitget
ECOR: Record revenue growth and leadership transition set the stage for 30% growth in 2026 - TradingView
electroCore Q4 Earnings Call Highlights - MarketBeat
ElectroCore says Dan Goldberger to retire as CEO effective April 1, 2026 - marketscreener.com
ECOR: Record revenue growth in 2025, leadership transition, and 30% growth targeted for 2026 - TradingView
electroCore, Inc. (ECOR) Reports Q4 Loss, Lags Revenue Estimates - Yahoo Finance
electroCore, Inc. reports results for the quarter ended December 31Earnings Summary - TradingView
Earnings call transcript: Electrocore Q4 2025 reports strong revenue growth By Investing.com - Investing.com Canada
electroCore 10-K: $32.0M Revenue, $(13.97)M Net Loss - TradingView
ElectroCore announces full year 2025 financial results and organizational changes - marketscreener.com
Electrocore Announces Full Year 2025 Financial Results And Organizational Changes - TradingView
Government-heavy revenue and risk profile at electroCore (NASDAQ: ECOR) - Stock Titan
Finanzdaten der Electrocore Inc-Aktie (ECOR)
Umsatz
Nettogewinn
Free Cashflow
ENV
Electrocore Inc-Aktie (ECOR) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Goldberger Daniel S | Chief Executive Officer |
Dec 02 '25 |
Buy |
4.84 |
1,000 |
4,840 |
292,565 |
| Lev Joshua S. | Chief Financial Officer |
Nov 12 '25 |
Sale |
6.18 |
2,166 |
13,386 |
23,667 |
| Errico Thomas J. | Director |
Aug 11 '25 |
Buy |
4.47 |
15,000 |
67,050 |
281,401 |
| Goldberger Daniel S | Chief Executive Officer |
Aug 11 '25 |
Buy |
4.23 |
1,000 |
4,230 |
291,565 |
| GANDOLFO JOHN P | Director |
May 23 '25 |
Buy |
5.01 |
1,800 |
9,018 |
69,087 |
| Errico Thomas J. | Director |
May 12 '25 |
Buy |
4.77 |
10,000 |
47,735 |
266,401 |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):